It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Reduction of elastin in the skin causes various skin diseases as well as wrinkles and sagging with aging. Sialidase is a hydrolase that cleaves a sialic acid residue from sialoglycoconjugate. Cleavage of sialic acid from microfibrils by the sialidase isozyme Neu1 facilitates elastic fiber assembly. In the present study, we showed that a lower layer of the dermis and muscle showed relatively intense sialidase activity. The sialidase activity in the skin decreased with aging. Choline and geranate (CAGE), one of the ionic liquids, can deliver the sialidase subcutaneously while maintaining the enzymatic activity. The elastin level in the dermis was increased by applying sialidase from Arthrobacter ureafaciens (AUSA) with CAGE on the skin for 5 days in rats and senescence-accelerated mice prone 1 and 8. Sialidase activity in the dermis was considered to be mainly due to Neu2 based on the expression level of sialidase isozyme mRNA. Transdermal administration of Neu2 with CAGE also increased the level of elastin in the dermis. Therefore, not only Neu1 but also Neu2 would be involved in elastic fiber assembly. Transdermal administration of sialidase is expected to be useful for improvement of wrinkles and skin disorders due to the loss of elastic fibers.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 University of Shizuoka, Department of Biochemistry, School of Pharmaceutical Sciences, Shizuoka, Japan (GRID:grid.469280.1) (ISNI:0000 0000 9209 9298)
2 Harvard University, School of Engineering and Applied Sciences, Cambridge, USA (GRID:grid.38142.3c) (ISNI:000000041936754X)
3 University of Shizuoka, Laboratory of Synthetic Organic and Medicinal Chemistry, School of Pharmaceutical Sciences, Shizuoka, Japan (GRID:grid.469280.1) (ISNI:0000 0000 9209 9298)
4 University of Shizuoka, Department of Functional Anatomy, School of Nursing, Shizuoka, Japan (GRID:grid.469280.1) (ISNI:0000 0000 9209 9298)
5 Hiroshima International University, Department of Organic Chemistry, School of Pharmaceutical Sciences, Hiroshima, Japan (GRID:grid.412153.0) (ISNI:0000 0004 1762 0863)